NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Similar documents
NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Direct Intravenous (IV) Medication Administration Procedure

Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

SARASOTA MEMORIAL HOSPITAL

Risk Management in Parenteral Nutrition. J. Boullata

Guideline scope Neonatal parenteral nutrition

The Drug Shortage Crisis

E.N : Tubal Feeding Systems ; Closed vs. Open

OBJECTIVES PRINCIPLES AND PRACTICES OF ASEPSIS

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Optimal nutrition in critically ill children

247 CMR BOARD OF REGISTRATION IN PHARMACY

Hyperglycemia Procedure: Management and Treatment Adult Patients

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018

Methods of Nutrition Support KNH 406

Infection Control Manual Residential Care Part 2 Infection Control Program Guidelines IC3: CCHSA Standards

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

MEDICAL POLICY: Enteral and Parenteral Nutrition

Environmental, Health and Safety

Latex and Occupational Dermatitis Policy Incorporating Glove Selection

The Role of the Responsible Pharmacist (RP)

Effective Date: 03/04

REVISION EFFECTIVE DATE N/A

Chapter 64 Administration of Injectable Medications

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 October 2011

Chiropractic Micro-Nutrient Therapy

Nutrition Therapy. Medical Coverage Policy Enteral/Parenteral EFFECTIVE DATE: POLICY LAST UPDATED: 11/20/2018 OVERVIEW

INFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust)

Review and comments on the 2014 recommendations for parenteral nutrition usage by ASPEN

Parenteral Nutrition in the Hospitalized Patient: which VAD, which policies? Rob Dawson DNP, MSA, APRN, ACNP-BC, VA-BC USA

About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.

What s In The Bag? 3-in-1 versus 2-in-1 PN

REVISED CODEX GENERAL STANDARD FOR IRRADIATED FOODS CODEX STAN , REV

RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA

Patient information leaflet. Royal Surrey County Hospital. NHS Foundation Trust. Parenteral Nutrition. Nutrition Support Team (NST)

SENATE, No STATE OF NEW JERSEY. 218th LEGISLATURE INTRODUCED FEBRUARY 5, 2018

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY

TOTAL PARENTERAL NUTRITION

SECTION PRESCRIPTIONS

SCHEDULE 2 THE SERVICES

Nutrition care plan for surgical patients. Objectives

NANDTB-F012 Rev 0 Audit Checklist

ASEPTIC DISPENSING TECHNIQUES/DRUG- NUTRIENT INTERACTIONS

The Impact of Healthcare Associated Infection (HCAI)

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK)

PPG Single Use Medical Devices

COURSE SYLLABUS. For PTHA The Profession of Physical Therapy CATALOGUE DESCRIPTION

Allergen and Gluten Free Options Use the following steps to determine if you should pursue the allergen/gluten free market

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist

Practice Direction Standard of Practice # 5: Administration of Drugs including Vaccines

Commercial Feed Mill Verification Task Procedures

Safe and effective prescribing of nutrition: the impact of dietitian prescribing rights in New Zealand

Aspen Parenteral Nutrition Guidelines

Effect of changing lipid formulation in Parenteral Nutrition in the Newborn Experimental Pathology BSc

Agency Information Collection Activities; Submission for Office of Management and Budget

concentrate intravenous solution and other strong potassium solutions

Urinary Catheters. Prevalence of Infections

Who Needs Parenteral Nutrition? Is Parenteral Nutrition An Appropriate Intervention?

WEST COAST DISTRICT MUNICIPALITY SUBSTANCE ABUSE POLICY

PARENTERAL NUTRITION

Improving Patient Safety and Compliance

Infection Control Basics:

Policy: S5 Smoke Free Policy

BD PosiFlush Pre-Filled Syringes * Average reflux as measured in 4Fr PICC; data on file at BD.

Provincial Clinical Knowledge Topic Insulin Pump Therapy, Pediatric and Adult Acute Care V 1.0

Complete Policy Title: Tobacco & Smoke Free Campus Policy Approved by: Board of Governors (anticipated) Policy Number (if applicable):

Hand Hygiene: Preventing avoidable harm in our care

Blood & Blood Product Administration

INPATIENT USE OF PARENTERAL PROSTACYCLINS IN AN ACADEMIC MEDICAL CENTER

JOB SPECIFICATION FORM NO: HR-SOP Environment, Health & Safety Manager. Overview and Job purpose

(cf / / Exposure Control Plan for Bloodborne Pathogens)

The Atlantic Canada Association of Reflexology Therapists

Colgate University. Bloodborne Pathogens Exposure Control Plan

Peninsula Dental Social Enterprise (PDSE)

SOUTH DAKOTA BOARD OF REGENTS. Policy Manual

Darwin Marine Supply Base HSEQ Quality Management Plan

BAY-ARENAC BEHAVIORAL HEALTH AUTHORITY POLICIES AND PROCEDURES MANUAL

AuSPEN Micronutrient Guidelines Review Where we up to?

10/28/2015. Disclaimer. Disclaimer

Describe the influence of pathomechanics on function.

Standards, Education, Verification. Patient Focused Certification

C30-A2 ISBN ISSN Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline Second Edition

X: Infusion Therapy. Saskatchewan Association of Licensed Practical Nurses, Competency Profile for LPNs, 3rd Ed. 201

4 PARENTERAL THERAPY

WORK HEALTH & SAFETY NEWSLETTER November

This program will outline infection prevention measures known to help reduce the risk of patients getting a healthcare associated infection (HAI).

Presentation to Parliamentary Portfolio Committee on Health

DRUG AND ALCOHOL POLICY

Clinical Policy: Total Parenteral Nutrition and Intradialytic Parenteral Nutrition Reference Number: CP.PHAR.205

Principles and Practices of Asepsis

ESPGHAN ESPEN Guidelines on Paediatric Parenteral Nutrition

Aminosteril N-Hepa 8%, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Intravenous Fluid and Drug Therapy

Transcription:

TITLE PARENTERAL NUTRITION ADMINISTRATION AND MONITORING SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Pharmacy Services, Nutrition Services, and Health Professions Strategy and Practice (Nursing) PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable DOCUMENT # HCS-218 INITIAL EFFECTIVE DATE November 1, 2018 REVISION EFFECTIVE DATE Not applicable SCHEDULED REVIEW DATE November 1, 2021 NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. If you have any questions or comments regarding the information in this document, please contact the Policy & Forms Department at policy@ahs.ca. The Policy & Forms website is the official source of current approved policies, procedures, directives, standards, protocols and guidelines. OBJECTIVES To facilitate the safe storage, administration, and monitoring of parenteral nutrition (PN) by standardizing best practice within Alberta Health Services (AHS) settings for adult, pediatric, and neonatal patients. PRINCIPLES Parenteral nutrition (PN) is a high-alert medication. Compliance with the AHS Management of High-Alert Medications Policy and related procedures is required. AHS is committed to patient safety and minimizing the risk of complications involving the care and management of patients receiving PN. Patients receiving PN are at a higher risk of infection. APPLICABILITY Compliance with this document is required by all Alberta Health Services employees, members of the medical and midwifery staffs, Students, Volunteers, and other persons acting on behalf of Alberta Health Services (including contracted service providers as necessary), working in Acute Care. ELEMENTS 1. Parenteral Nutrition (PN) Orders 1.1 When patients are admitted or transferred from another setting, medication reconciliation shall be completed in accordance with the AHS Medication Alberta Health Services (AHS) PAGE: 1 OF 5

Reconciliation Policy to ensure appropriate review, evaluation, and reconciliation of PN. 1.2 PN shall be ordered by an authorized prescriber using the appropriate standardized order set/form(s). 1.3 PN orders shall be carried out in accordance with the AHS Medication Orders Policy and Procedures and the AHS Parenteral Nutrition Management Policy. a) A titration order is required from an authorized prescriber to make ongoing rate adjustments. 2. Infection Control Measures 2.1 Health care professionals shall adhere to infection control measures including appropriate aseptic technique as required, to reduce the risk of contamination and infection that can occur through manipulation of PN, the vascular access device (VAD), and administration sets. 2.2 PN shall be stored in such a manner as to maintain appropriate temperature and reduce the risk of oxidation and contamination, as per the AHS Provincial Parenteral Monographs and/or manufacturer s recommendations. 2.3 Infection control measures shall include: a) hand hygiene prior to any manipulation of the PN system as per the AHS Hand Hygiene Policy and Procedure; b) a dedicated venous access line and/or lumen for PN should be used; c) aseptic management of the vascular access device (VAD) in alignment with standard infusion therapy practice; d) maintenance of the PN infusion as a closed system by avoiding disconnections for medication administration, diagnostic tests, or patient transfer; e) infusion of all lipid emulsions and amino acid dextrose solutions through filters appropriate for the type of formulation; f) priming of PN administration sets on the unit just prior to the time of infusion on the unit; and g) hang/infusion times that are appropriate for the type of PN formulation. 3. Roles and Responsibilities 3.1 Administration of PN is a restricted activity. For specific conditions that apply to a profession s authorization to administer PN, please consult the applicable discipline-specific regulation under the Health Professions Act (Alberta). Alberta Health Services (AHS) PAGE: 2 OF 5

3.2 It is the responsibility of health care professionals who handle PN to self-identify learning needs and undertake appropriate measures to ensure ongoing and continual competency, as determined by AHS and specific work settings. PN shall be administered and/or monitored by a health care professional who has: a) clinical competency in intravenous therapy management including vascular access devices (VAD); b) completed the AHS Provincial Infusion Pump Education and/or sitespecific practice setting education and training on infusion pumps; c) received PN education on administration and/or monitoring as per scope of practice; and d) clinical competency in PN administration and/or monitoring. 4. Independent Double-Check 4.1 Health care professionals, working within their scope of practice, shall perform the independent double-check for PN prior to administration as per the AHS Independent Double-Check Guideline. 5. Administration 5.1 PN shall be administered to the patient with appropriate equipment and in accordance with the safe practices and equipment policies (including but not limited to the AHS Provincial Parenteral Monographs, AHS Infusion Pumps for Medication & Parenteral Fluid Administration Policy, AHS Invasive Infusion Line and Tubing Verification Policy, AHS Parenteral Nutrition Administration and Monitoring Procedures and AHS Parenteral Nutrition Management Policy). a) Di-ethylhexyl-phthalate (DEHP)-free equipment is required for administration of all lipid emulsions and any amino acid dextrose solution tubing that may be connected to this equipment. 5.2 Provision of PN in Acute Care facilities shall be in accordance with the AHS Parenteral Nutrition Management Policy. a) Health care professionals shall be aware of their roles in administration and monitoring, including when patients in the Home PN Program are admitted to Acute Care. 5.3 Regular monitoring and ongoing assessment of patient health needs and the integrity of PN solutions and/or the delivery system (tubing / infusion pump) is required. For more information, see the AHS Parenteral Nutrition Administration and Monitoring Procedures. Alberta Health Services (AHS) PAGE: 3 OF 5

6. Patient Education 6.1 The health care professional shall provide education on PN administration and monitoring to the patient and/or family/caregiver. 7. Documentation DEFINITIONS 7.1 Documentation of PN administration and monitoring shall be done in accordance with legal, regulatory, and AHS (provincial, Zone or site) policy and procedure requirements for handwritten or electronic records. Alberta Health Services (AHS) settings means any environment where treatment/procedures and other health services are delivered by, on behalf of or in conjunction with, Alberta Health Services. Amino acid dextrose solution means a complex formulation of dextrose, amino acids, electrolytes, minerals, vitamins and trace elements. Authorized prescriber means a health care professional who is permitted by Federal and Provincial legislation, their regulatory college, Alberta Health Services, and practice setting (where applicable) to prescribe medications. Hand hygiene means practices which remove micro-organisms, with or without soil, from the hands (refers to the application of alcohol-based hand rub or the use of plain/antimicrobial soap, and water hand washing). Hang/infusion time means the period of time beginning with the flow of a fluid to the patient through an administration set and catheter and ending with the completion of the infusion. Health care professional means an individual who is a member of a regulated health discipline, as defined by the Health Disciplines Act (Alberta) or the Health Professions Act (Alberta), and who practices within scope and role. High-alert medication(s) means medications that bear a heightened risk of causing significant patient harm when used in error. Independent double-check means a verification process whereby a second health care professional conducts a verification of another health care professional s completed task. The most critical aspect is to maximize the independence of the double-check by ensuring that the first health care professional does not communicate what they expect the second health care professional to see, which would create bias and reduce the visibility of an error. Lipid emulsion means mixture of one (1) or more fats for intravenous use. Lipid emulsions are available in different types and volumes. Parenteral nutrition (PN) means intravenous provision of nutritional needs for a patient who is unable to take appropriate amounts of nutrition enterally; typical components include Alberta Health Services (AHS) PAGE: 4 OF 5

carbohydrates, proteins, and/or lipids/fats, as well as additives such as electrolytes, vitamins, and trace elements. Patient means all persons who receive or have requested health care or services from AHS and its health care providers and also means, where applicable: a) A co-decision-maker with the person; or b) An alternate decision-maker on behalf of the person. REFERENCES Alberta Health Services Governance Documents: o Adult Parenteral Nutrition Administration and Monitoring Procedure (#HCS-218-01) o Do Not Use List of Abbreviations, Symbols, and Dose Designations For Medication- Related Documentation Policy (#PS-08) o Hand Hygiene Policy and Procedure (#PS-02) o Independent Double-Check Guideline (#PS-60-01) o Infusion Pumps for Medication & Parenteral Fluid Administration Policy (#PS-70) o Invasive Infusion Line and Tubing Verification Policy (#PS-15) o Management of High Alert Medications Policy (#PS-46) o Medication Orders Policy and Procedures (#PS-93) o Medication Reconciliation Policy (#PS-05) o Neonatal Parenteral Nutrition Administration and Monitoring Procedure (#HCS-218-02) o Parenteral Nutrition Management Policy (#HCS-217) o Patient Identification Policy (#PS-06) o Pediatric Parenteral Nutrition Administration and Monitoring Procedure (#HCS-218-03) Alberta Health Services Resources: o Provincial Parenteral Monographs Non-Alberta Health Services Documents: o Clinical Standards: Parenteral Nutrition Ordering, Order Review, Compounding, Labelling, and Dispensing, 2014 (American Society for Parenteral and Enteral Nutrition [ASPEN]) o Health Professions Act (Alberta) o Parenteral Nutrition Safety Consensus Recommendations, 2014 (American Society for Parenteral and Enteral Nutrition [ASPEN]) VERSION HISTORY Date Click here to enter a date Click here to enter a date Action Taken Optional: Choose an item Optional: Choose an item Alberta Health Services (AHS) PAGE: 5 OF 5